Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Blood (2016) 128 (22): 4010.

https://doi.org/10.1182/blood.V128.22.4010.4010

Published: 2016

Journal Articles

Multiple Packed Red Blood Cell (PRBC) Transfusions In Pediatric Patients With Acute Myeloid Leukemia (AML) Result In a Large Transfusional Iron Dose With The Potential For Long-Term Organ Dysfunction

Mohammed Al-Darwish, MD, Asim F Belgaumi, MD, Neameh A Farhan, MSN, Ali Al-Ahmari, MD, Amal Al-Seraihy, Suleiman Alsweedan, MD, Wafaa Abdelghany, MD, FRCPath, MRCP, Hassan El-Solh, MD

Blood (2013) 122 (21): 2660.

https://doi.org/10.1182/blood.V122.21.2660.2660

Published: 2013

Journal Articles

Outcome Of Hematopoietic Cell Transplantation (HCT) In Pediatric Patients With Non-Hodgkin Lymphoma (NHL): Single Institution Results From Saudi Arabia

Asim F Belgaumi, MD, Hassan A Sumaili, MD, Amani A Al-Kofide, MD, Mouhab Ayas, MD, Hassan El-Solh, MD, Ali Al-Ahmari, MD, Abdallah Al-Jefri, MD, Mohammed Anas, BSN, Amal Mohamed, MSN, Amal Al-Seraihy

Blood (2013) 122 (21): 5522.

https://doi.org/10.1182/blood.V122.21.5522.5522

Published: 2013

Journal Articles

Outcome Of Hematopoietic Cell Transplantation (HCT) In Pediatric Patients With Hodgkin Lymphoma (HL): Single Institution Results From Saudi Arabia

Hassan A Sumaili, MD, Asim F Belgaumi, MD, Amani A Al-Kofide, MD, Amal Al-Seraihy, Hassan El-Solh, MD, Abdallah Al-Jefri, MD, Ali Al-Ahmari, MD, Amal Mohamed, MSN, Mohammed Anas, BSN, Mouhab Ayas, MD

Blood (2013) 122 (21): 5530.

https://doi.org/10.1182/blood.V122.21.5530.5530

Published: 2013

Journal Articles

Erythrocytosis Post Allogeneic Stem Cell Transplantation, An Observational Study Of Hemoglobin Levels On Long-Term Follow Up Post Transplantation In Patients With Fanconi Or Acquired Aplastic Anemia

Mouhab Ayas, MD, Khawar Siddiqui, MSc, Abdulrahman Al-Musa, MD, Hassan El-Solh, MD, Abdullah Al-Jefri, MD, Ali Al-Ahmari, MD, Ashraf Khairi, MD, Samer Markiz, MD, Amal Mohamad, RN, Amal Al-Seraihy

Blood (2013) 122 (21): 4643.

https://doi.org/10.1182/blood.V122.21.4643.4643

Published: 2013

Journal Articles

Factors Affecting Outcome of Related Allogeneic Hematopoietic Cell Transplantation in Patients with Fanconi Anemia.

Mouhab F Ayas, MD, Khawar Siddiqui, MSc, Amal Al-Seraihy, MD, Hassan El-Solh, MD, Ali Al-Ahmari, MD, Abdulrahman Al-Musa, MD, Ashraf Khairi, MD, Samer Markiz, MD, Hasan Shahin, MD, Viqaruddin Mohammed, Abdullah Al-Jefri, MD

Blood (2012) 120 (21): 3100.

https://doi.org/10.1182/blood.V120.21.3100.3100

Published: 2012

Journal Articles

Cytogenetic Risk Remains a Major Predictor of Outcome in Pediatric AML and ALL Treated with Allogeneic Stem Cell Transplantation,

Claudia Ulrike Walter, PhD, Mouhab Ayas, Amal Alseraihy, M.D., Hassan El-Solh, MD, Abdullah Al-Jefri, M.D., Ali Al-Ahmari, MD, Asim F Belgaumi, MD, Maher Albitar, M.D.

Blood (2011) 118 (21): 3524.

https://doi.org/10.1182/blood.V118.21.3524.3524

Published: 2011

Journal Articles

CD64 Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Maher Albitar, M.D., Amal Alseraihy, M.D., Mouhab Ayas, Abdullah Al-Jefri, M.D., Ali Al-Ahmari, MD, Asim F Belgaumi, MD, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hassan El-Solh, MD

Blood (2011) 118 (21): 3525.

https://doi.org/10.1182/blood.V118.21.3525.3525

Published: 2011

Journal Articles

Chimerism Analysis of Free Circulating DNA in the Prediction of Relapse in Patients with Acute Leukemia Treated with Stem Cell Transplantation,

Mahmoud Aljurf, M.D., Hala Abalkhail, PhD, Amal Alseraihy, M.D., Mouhab Ayas, Abdullah Al-Jefri, M.D., Ali Al-Ahmari, MD, Asim F Belgaumi, MD, Claudia Ulrike Walter, PhD, Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Hassan El-Solh, MD, Maher Albitar, M.D.

Blood (2011) 118 (21): 3533.

https://doi.org/10.1182/blood.V118.21.3533.3533

Published: 2011

Journal Articles

The AG Genotype of the Wilms Tumor-1 rs16754 SNP Is Associated with Poor Outcome in Pediatric AML Patients Treated with Stem Cell Transplantation but Not in Adults

Hala Abalkhail, PhD, Hassan El-Solh, MD, Amal Alseraihy, M.D., Mouhab Ayas, Ali Al-Ahmari, MD, Asim F Belgaumi, MD, Abdullah Al-Jefri, M.D., Ola Altombakty, MT, Mohammed Toulimat, MT, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Claudia Ulrike Walter, PhD, Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 5237.

https://doi.org/10.1182/blood.V118.21.5237.5237

Published: 2011

Journal Articles

Most Risk-Stratification Molecular Markers in Acute Myeloid Leukemia (AML) Are Rarely Found in Early Childhood AML in the Middle Eastern Population

Hala Abalkhail, PhD, Hassan El-Solh, MD, Amal Alseraihy, M.D., Asim F Belgaumi, MD, Abdullah Al-Jefri, M.D., Mouhab Ayas, Ali Al-Ahmari, MD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Claudia Ulrike Walter, PhD, Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 5239.

https://doi.org/10.1182/blood.V118.21.5239.5239

Published: 2011

Journal Articles

CD11b Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Blood (2011) 118 (21): 4092.

https://doi.org/10.1182/blood.V118.21.4092.4092

Published: 2011

Journal Articles

Outcome of Risk Adapted Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia in Children: Results From a Single Institution

Asim F Belgaumi, MD, Asem Bukhari, MD, Mohammed Al-Mahr, MD, Amal Al-Seraihy, MD, Hazem Mahmoud, MD, Abdulrahman Al-Musa, MD, Mahasen Saleh, MD, Ali Al-Ahmari, MD, Mouhab F Ayas, MD, Viqaruddin Khaja, MSc, Hassan El-Solh, MD

Blood (2011) 118 (21): 4237.

https://doi.org/10.1182/blood.V118.21.4237.4237

Published: 2011

Journal Articles

Risk Factors for Acute Graft-Versus-Host Disease After Related Hematopoietic Cell Transplantation in Children with Acute Leukemia

Mouhab F Ayas, MD, Khawar Siddiqui, MSc, Amal Al-Seraihy, MD, Abdallah Al-Jefri, MD, Ashraf Khairi, MD, Mohamed Al-Hinai, MD, Ali Al-Ahmari, MD, Asim F Belgaumi, MD, Hassan El-Solh, MD

Blood (2011) 118 (21): 1983.

https://doi.org/10.1182/blood.V118.21.1983.1983

Published: 2011

Journal Articles

Downs Syndrome Patients with Acute Lymphoblastic Leukemia; an Intermediate Outcome with a High Infectious Morbidity.

Mahasen Saleh, MD, Ashraf R. Khairy, MD, Hassan El-Solh, MD, Mohammed Al-Mahr, MD, Abdulrahman Al-Musa, MD, Amel Al-Seraihy, MD, Ali Al-Ahmari, MD, Asim F. Belgaumi, MD

Blood (2006) 108 (11): 4521.

https://doi.org/10.1182/blood.V108.11.4521.4521

Published: 2006

Journal Articles

Effective Treatment of Biphenotypic Acute Leukemia in Children with Chemotherapy Alone.

Amal S. Al-Seraihy, MD, Mouhab Ayas, MD, Tarek Owaidah, MD, Hassan El-Solh, MD, Mohammed Al-Mahr, MD, Abdulrahman Al-Musa, MD, Mahasen S. Al-Saleh, MD, Ali Al-Ahmari, MD, Asim F. Belgaumi, MD

Blood (2006) 108 (11): 4522.

https://doi.org/10.1182/blood.V108.11.4522.4522

Published: 2006

Journal Articles

The Outcome of Children with T-Cell Acute Lymphoblastic Leukemia: A Single Institution Experience.

Ali Al-Ahmari, MD, Asim F. Belgaumi, MD, Abdelmuniem Al-Dalee, PhD, Mohammed Al-Mahr, MD, Abdulrahman Al-Musa, MD, Mahasen Saleh, MD, Amal S. Al-Seraihy, MD, Ashraf R. Khairy, MD, Hassan El-Solh, MD

Blood (2006) 108 (11): 4526.

https://doi.org/10.1182/blood.V108.11.4526.4526

Published: 2006

Journal Articles

Long-Term Results of a Low-Dose Cytarabine-Based Regimen for the Treatment of Acute Megakaryoblastic Leukemia and Myelodysplastic Syndrome in Children with Down Syndrome.

Johann Hitzler, MD, Ali Al-Ahmari, MD, Niketa Shah, MD, Lillian Sung, MD, PhD, Alvin Zipursky, MD

Blood (2005) 106 (11): 4987.

https://doi.org/10.1182/blood.V106.11.4987.4987

Published: 2005

NARROW

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Multiple Packed Red Blood Cell (PRBC) Transfusions In Pediatric Patients With Acute Myeloid Leukemia (AML) Result In a Large Transfusional Iron Dose With The Potential For Long-Term Organ Dysfunction

Outcome Of Hematopoietic Cell Transplantation (HCT) In Pediatric Patients With Non-Hodgkin Lymphoma (NHL): Single Institution Results From Saudi Arabia

Outcome Of Hematopoietic Cell Transplantation (HCT) In Pediatric Patients With Hodgkin Lymphoma (HL): Single Institution Results From Saudi Arabia

Erythrocytosis Post Allogeneic Stem Cell Transplantation, An Observational Study Of Hemoglobin Levels On Long-Term Follow Up Post Transplantation In Patients With Fanconi Or Acquired Aplastic Anemia

Factors Affecting Outcome of Related Allogeneic Hematopoietic Cell Transplantation in Patients with Fanconi Anemia.

Cytogenetic Risk Remains a Major Predictor of Outcome in Pediatric AML and ALL Treated with Allogeneic Stem Cell Transplantation,

CD64 Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Chimerism Analysis of Free Circulating DNA in the Prediction of Relapse in Patients with Acute Leukemia Treated with Stem Cell Transplantation,

The AG Genotype of the Wilms Tumor-1 rs16754 SNP Is Associated with Poor Outcome in Pediatric AML Patients Treated with Stem Cell Transplantation but Not in Adults

Most Risk-Stratification Molecular Markers in Acute Myeloid Leukemia (AML) Are Rarely Found in Early Childhood AML in the Middle Eastern Population

CD11b Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Outcome of Risk Adapted Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia in Children: Results From a Single Institution

Risk Factors for Acute Graft-Versus-Host Disease After Related Hematopoietic Cell Transplantation in Children with Acute Leukemia

Downs Syndrome Patients with Acute Lymphoblastic Leukemia; an Intermediate Outcome with a High Infectious Morbidity.

Effective Treatment of Biphenotypic Acute Leukemia in Children with Chemotherapy Alone.

The Outcome of Children with T-Cell Acute Lymphoblastic Leukemia: A Single Institution Experience.

Long-Term Results of a Low-Dose Cytarabine-Based Regimen for the Treatment of Acute Megakaryoblastic Leukemia and Myelodysplastic Syndrome in Children with Down Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only